FDA Approves Groundbreaking Guided Missiles Drug for Advanced Breast Cancer
The US Food and Drug Administration (FDA) has approved a groundbreaking treatment for advanced breast cancer,marking a important milestone in oncology. The drug,named Datroway,was developed in partnership with the Japanese company Daiichi Sankyo and is designed for patients with HR-positive,HER2-negative breast cancer who have undergone prior treatments,including endocrine-based therapy and chemotherapy. This approval offers a … Read more